Bull Flag Stocks
OPK is forming a bull flag pattern, suggesting a potential continuation of its upward trend.
OPKO HEALTH INC (OPK) Stock Price & Overview
NASDAQ:OPK • US68375N1037
Current stock price
1.21 USD
+0.01 (+0.83%)
At close:
1.165 USD
-0.04 (-3.72%)
After Hours:
The current stock price of OPK is 1.21 USD. Today OPK is up by 0.83%. In the past month the price increased by 10%. In the past year, price decreased by -12.64%.
OPK Key Statistics
52-Week Range1.095 - 1.6
Current OPK stock price positioned within its 52-week range.
1-Month Range1.1079 - 1.26
Current OPK stock price positioned within its 1-month range.
- Market Cap
- 918.475M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -0.27
- Dividend Yield
- N/A
OPK Stock Performance
Today
+0.83%
1 Week
-0.82%
1 Month
+10.00%
3 Months
-3.97%
Longer-term
6 Months -11.03%
1 Year -12.64%
2 Years -0.82%
3 Years -17.69%
5 Years -70.49%
10 Years -88.74%
OPK Stock Chart
OPK Stock Screens
OPK currently appears in the following ChartMill screener lists.
OPK Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to OPK. When comparing the yearly performance of all stocks, OPK is a bad performer in the overall market: 78.57% of all stocks are doing better.
Chartmill TA Rating
Chartmill Setup Rating
OPK Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to OPK. While OPK seems to be doing ok healthwise, there are quite some concerns on its profitability.
Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
OPK Earnings
On April 28, 2026 OPK reported an EPS of -0.07 and a revenue of 124.20M. The company beat EPS expectations (0.99% surprise) and missed revenue expectations (-5.78% surprise).
Next Earnings DateJul 29, 2026
Last Earnings DateApr 28, 2026
PeriodQ1 / 2026
EPS Reported-$0.07
Revenue Reported124.2M
EPS Surprise 0.99%
Revenue Surprise -5.78%
OPK Forecast & Estimates
11 analysts have analysed OPK and the average price target is 3.47 USD. This implies a price increase of 186.61% is expected in the next year compared to the current price of 1.21.
For the next year, analysts expect an EPS growth of 6.21% and a revenue growth -7.84% for OPK
Analysts
Analysts80
Price Target3.47 (186.78%)
EPS Next Y6.21%
Revenue Next Year-7.84%
OPK Index Membership
OPK is currently included in the following stock indexes tracked on ChartMill.
OPK Financial Highlights
Over the last trailing twelve months OPK reported a non-GAAP Earnings per Share(EPS) of -0.27. The EPS decreased by -42.11% compared to the year before.
Income Statements
Revenue(TTM)606.88M
Net Income(TTM)-225.68M
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -11.68% | ||
| ROE | -17.8% | ||
| Debt/Equity | 0.27 |
Chartmill High Growth Momentum
EPS Q2Q%30%
Sales Q2Q%-17.14%
EPS 1Y (TTM)-42.11%
Revenue 1Y (TTM)-14.9%
OPK Ownership
Ownership
Inst Owners26.82%
Shares759.07M
Float385.13M
Ins Owners5.39%
Short Float %8.56%
Short Ratio14.41
OPK Industry Overview
OPK operates in the Health Care Services sub-industry within the Health Care sector. This group contains 50 stocks and is scored by ChartMill on both price strength and growth momentum.
Industry Strength Score
50/100
Composite price performance score based on 3, 6, and 12-month returns, with more weight on recent trends.
Industry Growth Score
88/100
Composite growth score based on earnings growth, revenue growth, and profitability across the sub-industry.
Relative Performance
Each rank shows how many other sub-industries were outperformed over that timeframe.
1 Month Rank
43%
Outperformed 43% of sub-industries
3 Month Rank
57%
Outperformed 57% of sub-industries
6 Month Rank
50%
Outperformed 50% of sub-industries
Industry Fundamentals & Breadth
- Members
- 50
- New Highs
- 10%
- New Lows
- 2%
- Average ROE
- 10.2%
- Average Profit Margin
- 2.8%
- Average Operating Margin
- 5.3%
- Average P/E
- 42.0
- Average Fwd P/E
- 27.4
- Average Debt/Equity
- 0.8
OPK Latest News, Press Relases and Analysis
11 hours ago - By: Chartmill
OPK Competitors/Peers
The largest stocks on the US markets in the "Health Care Services" sub-industry
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| CVS | CVS HEALTH CORP | 11.19 | 103.784B | ||
| CI | THE CIGNA GROUP | 9.12 | 75.122B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 99.72 | 30.602B | ||
| DGX | QUEST DIAGNOSTICS INC | 16.87 | 21.588B | ||
| LH | LABCORP HOLDINGS INC | 14.17 | 21.334B | ||
| GH | GUARDANT HEALTH INC | N/A | 10.899B | ||
| DVA | DAVITA INC | 10.63 | 10.025B | ||
| BTSG | BRIGHTSPRING HEALTH SERVICES | 29.89 | 9.174B | ||
| HIMS | HIMS & HERS HEALTH INC | 48 | 6.362B | ||
| CHE | CHEMED CORP | 15.66 | 6.152B | ||
| RDNT | RADNET INC | 88.48 | 4.493B | ||
| OPCH | OPTION CARE HEALTH INC | 14.61 | 4.36B | ||
| BLLN | BILLIONTOONE INC CL A | 160.6 | 3.596B |
Related stock screener links
View all stocks in the Health Care Services Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About OPK
Company Profile
OPKO Health, Inc. is a biopharmaceutical and diagnostics company, which engages in the provision of healthcare services. The company is headquartered in Miami, Florida and currently employs 2,275 full-time employees. The Company’s segments include pharmaceutical and diagnostics. The pharmaceutical segment consists of the pharmaceutical operations it operates in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its global pharmaceutical research and development operations. The diagnostics segment primarily consists of clinical laboratory operations through BioReference and its point-of-care operations. Its pharmaceutical business features Somatrogon (hGH-CTP), a once-weekly human growth hormone injection, and it is marketed under the brand name NGENLA. The Company, through its pharmaceutical division, manufactures and sells Rayaldee, a United States Food and Drug Administration (FDA) approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency.
Company Info
IPO: 1995-11-02
OPKO HEALTH INC
4400 Biscayne Blvd.
Miami FLORIDA 33137 US
CEO: Phillip Frost
Employees: 2275
Phone: 13055754181
OPKO HEALTH INC / OPK FAQ
Can you describe the business of OPKO HEALTH INC?
OPKO Health, Inc. is a biopharmaceutical and diagnostics company, which engages in the provision of healthcare services. The company is headquartered in Miami, Florida and currently employs 2,275 full-time employees. The Company’s segments include pharmaceutical and diagnostics. The pharmaceutical segment consists of the pharmaceutical operations it operates in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its global pharmaceutical research and development operations. The diagnostics segment primarily consists of clinical laboratory operations through BioReference and its point-of-care operations. Its pharmaceutical business features Somatrogon (hGH-CTP), a once-weekly human growth hormone injection, and it is marketed under the brand name NGENLA. The Company, through its pharmaceutical division, manufactures and sells Rayaldee, a United States Food and Drug Administration (FDA) approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency.
What is the stock price of OPKO HEALTH INC today?
The current stock price of OPK is 1.21 USD. The price increased by 0.83% in the last trading session.
Does OPKO HEALTH INC pay dividends?
OPK does not pay a dividend.
What is the ChartMill technical and fundamental rating of OPK stock?
OPK has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
What is the GICS sector and industry of OPK stock?
OPKO HEALTH INC (OPK) operates in the Health Care sector and the Health Care Providers & Services industry.
What is the expected growth for OPK stock?
The Revenue of OPKO HEALTH INC (OPK) is expected to decline by -7.84% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
What is OPKO HEALTH INC worth?
OPKO HEALTH INC (OPK) has a market capitalization of 918.47M USD. This makes OPK a Small Cap stock.